Apical and basolateral pools of proteinase-activated receptor-2 direct distinct signaling events in the intestinal epithelium

American Journal of Physiology - Cell Physiology

Volumn 300, Issue 1, 2011, Pages

  Lau, Chang ^a   Lytle, Christian ^b   Straus, Daniel S ^b   DeFea, Kathryn A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arrestin; Cofilin; Extracellular signal regulated kinase 1 2; Signal transduction

Indexed keywords

BETA ARRESTIN; CALCIUM ION; CHLORIDE; COFILIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOLIPASE C BETA; PROTEIN KINASE C; PROTEINASE ACTIVATED RECEPTOR 2; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN CELL; ILEUM; INTESTINE EPITHELIUM CELL; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ANIMALS; CACO-2 CELLS; CHLORIDES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HUMANS; ILEUM; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, PAR-2; SIGNAL TRANSDUCTION;

EID: 78651366621     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00162.2010     Document Type: Article

References (58)

1. Ahn S, Kim J, Hara MR, Ren XR, Lefkowitz RJ. β-Arrestin-2 mediates anti-apoptotic signaling through regulation of BAD phosphorylation. J Biol Chem 284: 8855-8865, 2009.
2. 2, in rat vascular and gastric smooth muscle. Can J Physiol Pharmacol 73: 1203-1207, 1995.
3. Bajwa PJ, Alioua A, Lee JW, Straus DS, Toro L, Lytle C. Fenofibrate inhibits intestinal Cl secretion by blocking basolateral KCNQ1 K+ channels. Am J Physiol Gastrointest Liver Physiol 293: G1288-G1299, 2007.
4. Barrett KE. Positive and negative regulation of chloride secretion in T84 cells. Am J Physiol Cell Physiol 265: C859-C868, 1993.
5. Camerer E, Huang W, Coughlin SR. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci USA 97: 5255-5260, 2000.
6. Cenac N, Chin AC, Garcia-Villar R, Salvador-Cartier C, Ferrier L, Vergnolle N, Buret AG, Fioramonti J, Bueno L. PAR2 activation alters colonic paracellular permeability in mice via IFN-γ-dependent and -independent pathways. J Physiol 558: 913-925, 2004.
7. Cenac N, Coelho AM, Nguyen C, Compton S, Andrade-Gordon P, MacNaughton WK, Wallace JL, Hollenberg MD, Bunnett NW, Garcia-Villar R, Bueno L, Vergnolle N. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am J Pathol 161: 1903-1915, 2002.
8. Cenac N, Garcia-Villar R, Ferrier L, Larauche M, Vergnolle N, Bunnett NW, Coelho AM, Fioramonti J, Bueno L. Proteinase-activated receptor-2-induced colonic inflammation in mice: possible involvement of afferent neurons, nitric oxide, and paracellular permeability. J Immunol 170: 4296, 2003.
9. Chen RH, Abate C, Blenis J. Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase. Proc Natl Acad Sci USA 90: 10952-10956, 1993.
10. Chen RH, Chung J, Blenis J. Regulation of pp90rsk phosphorylation and S6 phosphotransferase activity in Swiss 3T3 cells by growth factor, phorbol ester-, and cyclic AMP-mediated signal transduction. Mol Cell Biol 11: 1861-1867, 1991.
11. Chen RH, Tung R, Abate C, Blenis J. Cytoplasmic to nuclear signal transduction by mitogen-activated protein kinase and 90 kDa ribosomal S6 kinase. Biochem Soc Trans 21: 895-900, 1993.
12. Chin AC, Lee WY, Nusrat A, Vergnolle N, Parkos CA. Neutrophilmediated activation of epithelial protease-activated receptors-1 and -2 regulates barrier function and transepithelial migration. J Immunol 181: 5702-5710, 2008.
13. Coelho AM, Ossovskaya V, Bunnett NW. Proteinase-activated receptor- 2: physiological and pathophysiological roles. Curr Med Chem Cardiovasc Hematol Agents 1: 61-72, 2003.
14. Corvera CU, Dery O, McConalogue K, Bohm SK, Khitin LM, Caughey GH, Payan DG, Bunnett NW. Mast cell tryptase regulates rat colonic myocytes through proteinase-activated receptor 2. J Clin Invest 100: 1383-1393, 1997.
15. Corvera CU, Dery O, McConalogue K, Gamp P, Thoma M, Al Ani B, Caughey GH, Hollenberg MD, Bunnett NW. Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2. J Physiol 517: 741-756, 1999.
16. Cottrell GS, Amadesi S, Pikios S, Camerer E, Willardsen JA, Murphy BR, Caughey GH, Wolters PJ, Coughlin SR, Peterson A, Knecht W, Pothoulakis C, Bunnett NW, Grady EF. Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis. Gastroenterology 132: 2422-2437, 2007.
17. Cottrell GS, Coelho AM, Bunnett NW. Protease-activated receptors: the role of cell-surface proteolysis in signalling. Essays Biochem 38: 169-183, 2002.
18. Cottrell GS, Amadesi S, Grady EF, Bunnett NW. Trypsin IV, a novel agonist of protease-activated receptors 2 and 4. J Biol Chem 279: 13532-13539, 2004.
19. + absorption in the mouse distal colon. J Physiol 539: 209-222, 2002.
20. DeFea KA. Stop that cell! β-Arrestin-dependent chemotaxis: a tale of localized actin assembly and receptor desensitization. Annu Rev Physiol 69: 535-560, 2007.
21. DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD, Bunnett NW. Beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148: 1267-1281, 2000.
22. Dery O, Thoma MS, Wong H, Grady EF, Bunnett NW. Trafficking of proteinase-activated receptor-2 and beta-arrestin-1 tagged with green fluorescent protein: beta-arrestin-dependent endocytosis of a proteinase receptor. J Biol Chem 274: 18524-18535, 1999.
23. Fiorucci S, Mencarelli A, Palazzetti B, Distrutti E, Vergnolle N, Hollenberg MD, Wallace JL, Morelli A, Cirino G. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci USA 98: 13936-13941, 2001.
24. Fyfe M, Bergstr÷m M, Aspengren S, Peterson A. PAR-2 activation in intestinal epithelial cells potentiates interleukin-1β-induced chemokine secretion via MAP kinase signaling pathways. Cytokine 31: 358-367, 2005.
25. Ge L, Ly Y, Hollenberg M, DeFea K. A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis. J Biol Chem 278: 34418-34426, 2003.
26. Ge L, Shenoy SK, Lefkowitz RJ, DeFea K. Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2. J Biol Chem 279: 55419-55424, 2004.
27. Godeny MD, Sayeski PP. ERK1/2 regulates ANG II-dependent cell proliferation via cytoplasmic activation of RSK2 and nuclear activation of elk1. Am J Physiol Cell Physiol 291: C1308-C1317, 2006.
28. Hansen KK, Sherman PM, Cellars L, Andrade-Gordon P, Pan Z, Baruch A, Wallace JL, Hollenberg MD, Vergnolle N. A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis. Proc Natl Acad Sci USA 102: 8363-8368, 2005.
29. Hollenberg MD, Oikonomopoulou K, Hansen KK, Saifeddine M, Ramachandran R, Diamandis EP. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer. Biol Chem 389: 643-651, 2008.
30. Hollenberg MD, Renaux B, Hyun E, Houle S, Vergnolle N, Saifeddine M, Ramachandran R. Derivatized 2-furoyl-LIGRLO-amide, a versatile and selective probe for proteinase-activated receptor 2: binding and visualization. J Pharmacol Exp Ther 326: 453-462, 2008.
31. Hoogerwerf WA, Zou L, Shenoy M, Sun D, Micci MA, Lee-Hellmich H, Xiao SY, Winston JH, Pasricha PJ. The proteinase-activated receptor 2 is involved in nociception. J Neurosci 21: 9036-9042, 2001.
32. Hyun E, Andrade-Gordon P, Steinhoff M, Vergnolle N. Protease-activated receptor-2 activation: a major actor in intestinal inflammation. Gut 57: 1222-1229, 2008.
33. Jacob C, Yang PC, Darmoul D, Amadesi S, Saito T, Cottrell GS, Coelho AM, Singh P, Grady EF, Perdue M, Bunnett NW. Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins. J Biol Chem 280: 31936-31948, 2005.
34. Kajikawa H, Yoshida N, Katada K, Hirayama F, Handa O, Kokura S, Naito Y, Yoshikawa T. Helicobacter pylori Activates gastric epithelial cells to produce interleukin-8 via protease-activated receptor 2. Digestion 76: 248-255, 2007.
35. Kawabata A, Kuroda R. [PAR (protease-activated receptor) as a novel target for development of gastric mucosal cytoprotective drugs]. Nippon Yakurigaku Zasshi 120: 85P-87P, 2002.
36. Keely SJ, Uribe JM, Barrett KE. Carbachol stimulates transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T84 cells. J Biol Chem 273: 27111-27117, 1998.
37. Kong W, McConalogue K, Khitin LM, Hollenberg MD, Payan DG, Bohm SK, Bunnett NW. Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. Proc Natl Acad Sci USA 94: 8884-8889, 1997.
38. Kumar P, Lau CS, Mathur M, Wang P, DeFea K. Differential effects of β-arrestins on protease-activated-receptor-2 desensitization, internalizaiton and MAPK signaling. Am J Physiol Cell Physiol 293: C346-C367, 2007.
39. Lee JW, Wang P, Kattah MG, Youssef S, Steinman L, DeFea K, Straus DS. Differential regulation of chemokines by IL-17 in colonic epithelial cells. J Immunol 181: 6536-6545, 2008.
40. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. Proteinase-activated receptors. Pharmacol Rev 53: 245-282, 2001.
41. Mall M, Gonska T, Thomas J, Hirtz S, Schreiber R, Kunzelmann K. Activation of ion secretion via proteinase-activated receptor-2 in human colon. Am J Physiol Gastrointest Liver Physiol 282: G200-G210, 2002.
42. Marten NW, Hsiang CH, Yu L, Stollenwerk NS, Straus DS. Functional activity of hepatocyte nuclear factor-1 is specifically decreased in amino acid-limited hepatoma cells. Biochim Biophys Acta 1447: 160-174, 1999.
43. McGuire JJ, Saifeddine M, Triggle CR, Sun K, Hollenberg MD. 2-Furoyl-LIGRLO-amide: a potent and selective proteinase-activated receptor 2 (PAR-2) agonist. J Pharmacol Exp Ther 309: 1124-1131, 2004.
44. Ramachandran R, Mihara K, Mathur M, Rochdi MD, Bouvier M, DeFea K, Hollenberg MD. Agonist-biased signaling via proteinase activated receptor-2: differential activation of calcium and mitogen-activated protein kinase pathways. Mol Pharmacol 76: 791-801, 2009.
45. Sato S, Ito Y, Kondo M, Ohashi T, Ito S, Nakayama S, Shimokata K, Kume H. Ion transport regulated by protease-activated receptor 2 in human airway Calu-3 epithelia. Br J Pharmacol 146: 397-407, 2005.
46. Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene 20: 2390-2400, 2001.
47. Stalheim L, Ding Y, Gullapalli A, Paing MM, Wolfe BL, Morris DR, Trejo J. Multiple independent functions of arrestins in the regulation of protease-activated receptor-2 signaling and trafficking. Mol Pharmacol 67: 78-87, 2005.
48. Takeuchi T, Harris JL, Huang W, Yan KW, Coughlin SR, Craik CS. Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem 275: 26333-26342, 2000.
49. Tohgo A, Choy EW, Gesty-Palmer D, Pierce KL, Laporte S, Oakley RH, Caron MG, Lefkowitz RJ, Luttrell LM. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation. J Biol Chem 278: 6258, 2003.
50. Tremaine WJ, Brzezinski A, Katz JA, Wolf DC, Fleming TJ, Mordenti J, Strenkoski-Nix LC, Kurth MC. Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study. Aliment Pharmacol Ther 16: 407-413, 2002.
51. Van der Merwe JQ, Hollenberg MD, MacNaughton WK. EGF receptor transactivation and MAP kinase mediate proteinase-activated receptor-2-induced chloride secretion in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 294: G441-G451, 2008.
52. Van der Merwe JQ, Moreau F, MacNaughton WK. Protease-activated receptor-2 stimulates intestinal epithelial chloride transport through activation of PLC and selective PKC isoforms. Am J Physiol Gastrointest Liver Physiol 296: G1258-G1266, 2009.
53. Van der Merwe JQ, Ohland CL, Hirota CL, MacNaughton WK. Prostaglandin E2 derived from cyclooxygenases 1 and 2 mediates intestinal epithelial ion transport stimulated by the activation of proteaseactivated receptor 2. J Pharmacol Exp Ther 329: 747-752, 2009.
54. Wang P, DeFea K. Protease-activated-receptor-2 simultaneously directs beta-arrestin-dependent inhibition and G q-dependent activation of PI3K. Biochemistry 45: 9374-9385, 2006.
55. Wang P, Kumar P, Wang C, DeFea K. Differential regulation of class IA phosphoinositide 3-kinase catalytic subunits p110 alpha and beta by protease-activated-receptor 2 and beta-arrestins. Biochem J 428: 221-230, 2007.
56. Wei H, Ahn S, Shenoy SK, Karnik SS, Hunyady L, Luttrell LM, Lefkowitz RJ. Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc Natl Acad Sci USA 100: 10782-10787, 2003.
57. Zoudilova M, Kumar P, Ge L, Wang P, Bokoch GM, DeFea KA. Beta-arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2. J Biol Chem 282: 20634-20646, 2007.
58. Zoudilova M, Min J, Richards HL, Carter D, Huang T, DeFea KA. Beta-arrestins scaffold cofilin with chronophin to direct localized actin filament severing and membrane protrusions downstream of proteaseactivated receptor-2. J Biol Chem 285: 14318-14329, 2010.